(COLD) Americold Realty Trust - Overview
Stock: Warehouses, Logistics, Storage, Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 6.10% |
| Yield on Cost 5y | 3.05% |
| Yield CAGR 5y | 1.12% |
| Payout Consistency | 98.3% |
| Payout Ratio | 11.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 34.3% |
| Relative Tail Risk | -1.46% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.16 |
| Alpha | -52.21 |
| Character TTM | |
|---|---|
| Beta | 0.871 |
| Beta Downside | 0.888 |
| Drawdowns 3y | |
|---|---|
| Max DD | 67.06% |
| CAGR/Max DD | -0.34 |
Description: COLD Americold Realty Trust January 10, 2026
Americold Realty Trust (NYSE:COLD) is a publicly-traded REIT that owns, operates, acquires, and develops temperature-controlled warehouses worldwide. The company currently manages 235 facilities encompassing roughly 1.4 billion refrigerated cubic feet across North America, Europe, Asia-Pacific, and South America, positioning its assets as critical links in the food-supply chain from producers to end-consumers.
Key quantitative drivers to watch: (1) Occupancy rates have hovered above 95 % in the most recent quarter, reflecting strong demand for cold-storage capacity; (2) Average rent growth has outpaced general inflation, driven by e-commerce food delivery and the surge in perishable-goods imports; and (3) The REIT’s weighted-average lease term remains near 5 years, providing revenue stability amid macro-economic uncertainty. Sector-level trends-such as rising global food-waste regulations and expanding cold-chain requirements for pharmaceuticals-further underpin Americold’s growth outlook.
For a deeper, data-driven look at COLD’s valuation and risk profile, the ValueRay platform offers a concise, quantitative analysis that can help inform your next research step.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -62.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -3.34 > 1.0 |
| NWC/Revenue: -149.8% < 20% (prev -12.71%; Δ -137.1% < -1%) |
| CFO/TA 0.05 > 3% & CFO 392.0m > Net Income -62.4m |
| Net Debt (4.26b) to EBITDA (429.5m): 9.91 < 3 |
| Current Ratio: 0.09 > 1.5 & < 3 |
| Outstanding Shares: last quarter (285.9m) vs 12m ago 0.36% < -2% |
| Gross Margin: 31.95% > 18% (prev 0.32%; Δ 3163 % > 0.5%) |
| Asset Turnover: 32.69% > 50% (prev 33.98%; Δ -1.29% > 0%) |
| Interest Coverage Ratio: 0.51 > 6 (EBITDA TTM 429.5m / Interest Expense TTM 142.8m) |
Altman Z'' -4.70
| A: -0.48 (Total Current Assets 402.5m - Total Current Liabilities 4.31b) / Total Assets 8.08b |
| B: -0.32 (Retained Earnings -2.57b / Total Assets 8.08b) |
| C: 0.01 (EBIT TTM 72.4m / Avg Total Assets 7.98b) |
| D: -0.52 (Book Value of Equity -2.63b / Total Liabilities 5.01b) |
| Altman-Z'' Score: -4.70 = D |
Beneish M -3.18
| DSRI: 0.82 (Receivables 369.1m/460.3m, Revenue 2.61b/2.68b) |
| GMI: 0.99 (GM 31.95% / 31.55%) |
| AQI: 1.13 (AQ_t 0.28 / AQ_t-1 0.25) |
| SGI: 0.97 (Revenue 2.61b / 2.68b) |
| TATA: -0.06 (NI -62.4m - CFO 392.0m) / TA 8.08b) |
| Beneish M-Score: -3.18 (Cap -4..+1) = AA |
What is the price of COLD shares?
Over the past week, the price has changed by +2.01%, over one month by -4.16%, over three months by +8.62% and over the past year by -38.71%.
Is COLD a buy, sell or hold?
- StrongBuy: 7
- Buy: 5
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the COLD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 14.8 | 16.9% |
| Analysts Target Price | 14.8 | 16.9% |
| ValueRay Target Price | 11.8 | -6.9% |
COLD Fundamental Data Overview February 03, 2026
P/S = 1.3602
P/B = 1.1626
P/EG = 4.0258
Revenue TTM = 2.61b USD
EBIT TTM = 72.4m USD
EBITDA TTM = 429.5m USD
Long Term Debt = 3.54b USD (from longTermDebt, last quarter)
Short Term Debt = 4.29b USD (from shortTermDebt, last quarter)
Debt = 4.29b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.26b USD (from netDebt column, last quarter)
Enterprise Value = 7.80b USD (3.55b + Debt 4.29b - CCE 33.3m)
Interest Coverage Ratio = 0.51 (Ebit TTM 72.4m / Interest Expense TTM 142.8m)
EV/FCF = -52.84x (Enterprise Value 7.80b / FCF TTM -147.6m)
FCF Yield = -1.89% (FCF TTM -147.6m / Enterprise Value 7.80b)
FCF Margin = -5.66% (FCF TTM -147.6m / Revenue TTM 2.61b)
Net Margin = -2.39% (Net Income TTM -62.4m / Revenue TTM 2.61b)
Gross Margin = 31.95% ((Revenue TTM 2.61b - Cost of Revenue TTM 1.78b) / Revenue TTM)
Gross Margin QoQ = 30.89% (prev 32.53%)
Tobins Q-Ratio = 0.97 (Enterprise Value 7.80b / Total Assets 8.08b)
Interest Expense / Debt = 0.79% (Interest Expense 33.9m / Debt 4.29b)
Taxrate = 21.0% (US default 21%)
NOPAT = 57.2m (EBIT 72.4m * (1 - 21.00%))
Current Ratio = 0.09 (Total Current Assets 402.5m / Total Current Liabilities 4.31b)
Debt / Equity = 1.41 (Debt 4.29b / totalStockholderEquity, last quarter 3.03b)
Debt / EBITDA = 9.91 (Net Debt 4.26b / EBITDA 429.5m)
Debt / FCF = -28.82 (negative FCF - burning cash) (Net Debt 4.26b / FCF TTM -147.6m)
Total Stockholder Equity = 3.15b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.78% (Net Income -62.4m / Total Assets 8.08b)
RoE = -1.98% (Net Income TTM -62.4m / Total Stockholder Equity 3.15b)
RoCE = 1.08% (EBIT 72.4m / Capital Employed (Equity 3.15b + L.T.Debt 3.54b))
RoIC = 0.84% (NOPAT 57.2m / Invested Capital 6.81b)
WACC = 4.47% (E(3.55b)/V(7.84b) * Re(9.12%) + D(4.29b)/V(7.84b) * Rd(0.79%) * (1-Tc(0.21)))
Discount Rate = 9.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.29%
Fair Price DCF = unknown (Cash Flow -147.6m)
EPS Correlation: 15.00 | EPS CAGR: 2.09% | SUE: -0.23 | # QB: 0
Revenue Correlation: -77.43 | Revenue CAGR: -2.02% | SUE: 0.05 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.04 | Chg30d=+0.010 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=0.17 | Chg30d=-0.020 | Revisions Net=-1 | Growth EPS=+13.9% | Growth Revenue=-2.0%